This review highlights literature pertinent to chimerism analysis in the context of
hematopoietic cell transplantation (HCT). We also conducted a survey of testing practices of …

Allogeneic hematopoietic stem cell transplant (allo-HSCT) remains a key treatment option
for hematologic malignancies (HMs), although it carries significant risks. Up to 30% of …

Background Quantification of chimerism showing the proportion of the donor in a recipient is
essential for the follow-up of hematopoietic stem cell transplantation but can also be useful …

Background/aims Chimerism monitoring by means of high-throughput sequencing or
quantitative PCR of biallelic single nucleotide and insertion/deletion polymorphisms has …

Allogenic hematopoietic stem cell transplantation (allo-HSCT) is a life-saving treatment for
various hematological disorders. The success of allo-HSCT depends on the engraftment of …

Chimerism analysis after allogeneic hematopoietic stem cell transplantation serves to
confirm engraftment, indicate relapse of hematologic malignancy, and attribute graft failure …

Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative strategy for acute
myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The prediction of …

Developing an Allogeneic Hematopoietic Progenitor Cell Transplant Service in a Resource-Limited
Country: Challenges and Outcomes - PMC Back to Top Skip to main content NIH NLM Logo …

The Histocompatibility and Identity Testing Committee offers an overview of the College of
American Pathologists'(CAP) Proficiency Testing (PT) program, commemorating its …

Cytogenomic analyses of acquired clonal chromosomal abnormalities in neoplastic blood,
bone marrow, and/or lymph nodes are instrumental in the clinical management of patients …